Skip Nav Destination
Issues
Cancer Research
Table of Contents
Advances in Brief
Frequent Loss of Estrogen Receptor-β Expression in Prostate Cancer1
Lisa G. Horvath; Susan M. Henshall; C-Soon Lee; Darren R. Head; David I. Quinn; Sari Makela; Warick Delprado; David Golovsky; Phillip C. Brenner; Gordon O’Neill; Raji Kooner; Phillip D. Stricker; John J. Grygiel; Jan-Ake Gustafsson; Robert L. Sutherland
Growth Suppression of Intracranial Xenografted Glioblastomas Overexpressing Mutant Epidermal Growth Factor Receptors by Systemic Administration of Monoclonal Antibody (mAb) 806, a Novel Monoclonal Antibody Directed to the Receptor1
Kazuhiko Mishima; Terrance G. Johns; Rodney B. Luwor; Andrew M. Scott; Elisabeth Stockert; Achim A. Jungbluth; Xiang-Dong Ji; Padma Suvarna; Joseph R. Voland; Lloyd J. Old; H-J. Su Huang; Webster K. Cavenee
Monoclonal Antibody 806 Inhibits the Growth of Tumor Xenografts Expressing Either the de2–7 or Amplified Epidermal Growth Factor Receptor (EGFR) but not Wild-Type EGFR
Rodney B. Luwor; Terrance G. Johns; Carmel Murone; H-J. Su Huang; Webster K. Cavenee; Gerd Ritter; Lloyd J. Old; Antony W. Burgess; Andrew M. Scott
Repair of 8-Oxodeoxyguanosine Lesions in Mitochondrial DNA Depends on the Oxoguanine DNA Glycosylase (OGG1) Gene and 8-Oxoguanine Accumulates in the Mitochondrial DNA of OGG1-defective Mice
Nadja C. de Souza-Pinto; Lars Eide; Barbara A. Hogue; Tanja Thybo; Tinna Stevnsner; Erling Seeberg; Arne Klungland; Vilhelm A. Bohr
Biochemistry and Biophysics
Overexpression of Mitochondrial Manganese Superoxide Dismutase Protects against Radiation-induced Cell Death in the Human Hepatocellular Carcinoma Cell Line HLE1
Shigeatsu Motoori; Hideyuki J. Majima; Masaaki Ebara; Hirotoshi Kato; Futoshi Hirai; Shizuko Kakinuma; Chizuru Yamaguchi; Toshihiko Ozawa; Tetsuo Nagano; Hirohiko Tsujii; Hiromitsu Saisho
Carcinogenesis
Clinical Investigations
High Tumor Levels of Vascular Endothelial Growth Factor Predict Poor Response to Systemic Therapy in Advanced Breast Cancer1
John A. Foekens; Harry A. Peters; Nicolai Grebenchtchikov; Maxime P. Look; Marion E. Meijer-van Gelder; Anneke Geurts-Moespot; Theo H. van der Kwast; C. G. J. (Fred) Sweep; Jan G. M. Klijn
Epidemiology and Prevention
Red Meat, Family History, and Increased Risk of Gastric Cancer with Microsatellite Instability1
Domenico Palli; Antonio Russo; Laura Ottini; Giovanna Masala; Calogero Saieva; Andrea Amorosi; Alessandro Cama; Cristina D’Amico; Mario Falchetti; Raffaele Palmirotta; Adriano Decarli; Renato Mariani Costantini; Joseph F. Fraumeni, Jr.
Modification of BRCA1- and BRCA2-associated Breast Cancer Risk by AIB1 Genotype and Reproductive History1
Timothy R. Rebbeck; Yiting Wang; Philip W. Kantoff; Krishna Krithivas; Susan L. Neuhausen; Andrew K. Godwin; Mary B. Daly; Steven A. Narod; Jean-Sebastian Brunet; Daniel Vesprini; Judy E. Garber; Henry T. Lynch; Barbara L. Weber; Myles Brown
Experimental Therapeutics
Multimodality Therapy with a Replication-conditional Herpes Simplex Virus 1 Mutant that Expresses Yeast Cytosine Deaminase for Intratumoral Conversion of 5-Fluorocytosine to 5-Fluorouracil1
Hideo Nakamura; John T. Mullen; Soundararajalu Chandrasekhar; Timothy M. Pawlik; Sam S. Yoon; Kenneth K. Tanabe
CV706, a Prostate Cancer-specific Adenovirus Variant, in Combination with Radiotherapy Produces Synergistic Antitumor Efficacy without Increasing Toxicity1
Yu Chen; Theodore DeWeese; Jeanette Dilley; Yiwei Zhang; Yuanhao Li; Nagarajan Ramesh; Jake Lee; Rukmini Pennathur-Das; John Radzyminski; Joseph Wypych; Dominic Brignetti; Sara Scott; Jennifer Stephens; David B. Karpf; Daniel R. Henderson; De-Chao Yu
A-204197, a New Tubulin-binding Agent with Antimitotic Activity in Tumor Cell Lines Resistant to Known Microtubule Inhibitors
Stephen K. Tahir; Edward K-H. Han; Bruce Credo; Hwan-Soo Jae; Jennifer A. Pietenpol; Caroline D. Scatena; Jinshyun R. Wu-Wong; David Frost; Hing Sham; Saul H. Rosenberg; Shi-Chung Ng
Immunology
Molecular Biology and Genetics
Tumor Biology
Detection of Peritoneal Micrometastases of Gastric Carcinoma with Green Fluorescent Protein and Carcinoembryonic Antigen Promoter
Katsuhiko Kaneko; Masahiko Yano; Tomoki Yamano; Toshimasa Tsujinaka; Hirofumi Miki; Yosuke Akiyama; Masaaki Taniguchi; Yoshiyuki Fujiwara; Yuichiro Doki; Masatoshi Inoue; Hitoshi Shiozaki; Yasushi Kaneda; Morito Monden
Telomerase Inhibition in RenCa, a Murine Tumor Cell Line with Short Telomeres, by Overexpression of a Dominant Negative mTERT Mutant, Reveals Fundamental Differences in Telomerase Regulation between Human and Murine Cells1
Jana Sachsinger; Eva González-Suárez; Enrique Samper; Rüdiger Heicappell; Markus Müller; María. A. Blasco
Alterations of p14ARF, p53, and p73 Genes Involved in the E2F-1-mediated Apoptotic Pathways in Non-Small Cell Lung Carcinoma
Siobhan A. Nicholson; Nader T. Okby; Mohammed A. Khan; Judith A. Welsh; Mary G. McMenamin; William D. Travis; James R. Jett; Henry D. Tazelaar; Victor Trastek; Peter C. Pairolero; Paul G. Corn; James G. Herman; Lance A. Liotta; Neil E. Caporaso; Curtis C. Harris
Letters to the Editor
Obituary
Journal Archive
Cancer Research
(1941-Present; volumes 1-current)Published twice monthly since 1987. From 1941-1986, published monthly.
(ISSN 0008-5472)
The American Journal of Cancer
(1931-1940; volumes 15-40)Published quarterly in 1931, bimonthly in 1932, and monthly from 1933 to 1940. The journal changed title to Cancer Research in 1941.
(ISSN 0099-7374)
The Journal of Cancer Research
(1916-1930); volumes 1-14)Published quarterly from 1916 through 1930 (publication was suspended from November 1922 to March 1924). The journal changed title to The American Journal of Cancer in 1931.
(ISSN 0099-7013)
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio® (avelumab), a pharmaceutical owned by Merck. None of these funds are being, or will be, used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.
RSS Feeds